Acute Kidney Injury After Cardiac Arrest

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

82 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The development of AKI (Acute Kidney Injury) after cardiac arrest is a common factor associated with mortality. In this study, we aimed to evaluate the factors that increase the risk of developing AKI after cardiac arrest.

For the study, patients were evaluated for the incidence of acute kidney injury (AKI), factors that increase the risk of AKI, and the impact of AKI on mortality. In this process, demographic data, comorbidities, hemodynamic data, laboratory data, clinical symptoms and findings recorded in the electronic decision support system were recorded and analyzed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Incidence and Outcomes of Acute Kidney Injury in Trauma Patients Admitted to Critical Care

NCT05381493

Acute Kidney Injury Trauma; Complications

COMPLETED

Acute Kidney Injury Following Cardiac Surgery

NCT03102528

Acute Kidney Injury

COMPLETED

Assessment of Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery in Critical Patients

NCT03135483

Assesse Prevalence of Acute Kidney Injury and Myocardial Injury After Non Cardiac Surgery

UNKNOWN

Acute Kidney Injury in Critical COVID-19: Outcomes and Risks

NCT07089693

COVID -19 Acute Kidney Injury Intensive Care Unit (ICU) Admission +1 more

COMPLETED

Renal Arterial Resistive Index for Differential Diagnosis of Acute Kidney Injury

NCT05409690

Acute Kidney Injury

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This retrospective study was performed on patients hospitalized in intensive care units after cardiac arrest between 2013 and 2022. Patients who met the inclusion criteria were included in the study. Urea, creatinine values, and whether AKI was diagnosed or not were obtained from the data registry system. Statistical evaluation was performed using univariate binary logistic regression analysis.

Demographic data, location of cardiac arrest (in-hospital, out-of-hospital), and duration of CPR were recorded. In addition, the causes of cardiac arrest, HR/MAP (heart rate/average arterial pressure) ratio, and whether VSP (vasopressor) or INO (inotropic) medication was needed were recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AKI Group

AKI 1-3 in the first 48 hours after cardiac arrest according to KDIGO 2012 criteria

No interventions assigned to this group

Non-AKI Group

Those who did not develop AKI in the first 48 hours after cardiac arrest according to KDIGO 2012 criteria

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients with spontaneous circulation after cardiac arrest and admitted to the intensive care unit

Exclusion Criteria

* Deaths in the first 48 hours
* Missing data
* End stage CKD or first day hemadsorption
* CPR time \<3 min
* Unwitnessed cardiac arrest
* Terminal malignancy

* 90 years old
* Having a pace marker
* Massive bleeding
* ECMO application
* First day diyabetes insipitus

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No